The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Sponsored|December 16, 2021
New Cannabinoids Acids 7 Standard Simplifies Standard Prep and Reduces Errors
Author(s)Restek
With more cannabinoid acids than other standards on the market, Restek’s newest certified reference material offers a simpler solution for cannabis and hemp potency testing.
Containing seven of the most frequently analyzed cannabinoid acids, our cannabinoids acids 7 standard reduces the time, expense, and error associated with in-house preparation of mixed standards from single-compound solutions. The 1000 μg/mL formulation is two to four times more concentrated than other commercially available standards, meaning less volume is required when preparing calibration solutions or fortifying QC samples. Because less volume is needed and more compounds are included, labs have greater flexibility in developing appropriate working standards for the wide range of cannabinoids and sample types encountered in potency testing. In addition to simplifying standard preparation, overall lab efficiency is improved by using Restek’s seven-compound blend because single-component solutions do not have to be sourced, inventoried, and maintained. Independently produced lots are also available, so ISO and your quality program requirements can be met with a single order.
Restek’s new cannabinoid acids mix (cat.# 34144) contains the following compounds at 1000 μg/mL:
• Cannabichromenic acid (CBCA)
• Cannabidiolic acid (CBDA)
• Cannabidivarinic acid (CBDVA)
• Cannabigerolic acid (CBGA)
• Cannabinolic acid (CBNA)
• Tetrahydrocannabinolic acid (THCA-A)
• Tetrahydrocannabivarinic acid (THCVA)
For cannabinoid neutrals, other reference standards, sample preparation products, LC and GC columns, and technical resources for cannabis and hemp testing, visit www.restek.com/cannabis.
Restek Corporation
www.restek.com
1-814-353-1300, ext. 3
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!